Clinical Trial Update: Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and immune response of a novel HPV vaccine in HIV-infected children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Sexually Transmitted Diseases

Drugs mentioned

• novel human papillomavirus vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Sexually Transmitted Diseases | Phase 2 | Status: COMPLETED | Results posted: 2012-01-16